Metallomics · 2019 · 51 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyDrug DiscoveryCytotoxic ChemotherapyLigand BindingAnticancer ActivityAnticancer ChemotherapyAnticancer Compound ScreeningCancer Cell Proliferation InhibitionCell Viability AssaysMonolayersOrganoruthenium ChemistryPlatinum Compounds
The purpose of this work was to screen the antitumor actions of two metal organoruthenium-8-hydroxyquinolinato (Ru-hq) complexes to find a potential novel agent for bone, lung and breast chemotherapies. We showed that ruthenium compounds (1 and 2) impaired the cell viability of human bone (MG-63), lung (A549) and breast (MCF7) cancer cells with greater selectivity and specificity than cisplatin. Besides, complexes 1 and 2 decreased proliferation, migration and invasion on cell monolayers at lower concentrations (2.5-10 μM). In addition, both compounds induced genotoxicity revealed by the micronucleus test, which led to G2/M cell cycle arrest and induced the tumor cells to undergo apoptosis. On the other hand, in multicellular 3D models (multicellular spheroids; MCS), 1 and 2 overcame CDDP presenting lower IC50 values only in MCS of lung origin. Moreover, 1 outperformed 2 in MCS of bone and breast origin. Finally, our findings revealed that both compounds inhibited the cell invasion of multicellular spheroids, showing that complex 1 exhibited the most important antimetastatic action. Taken together, these results indicate that compound 1 is an interesting candidate to be tested on in vivo models as a novel strategy for anticancer therapy.
36
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl, Petra Heffeter, Christian R. Kowol et al. · Chemical Science · 2014 · 659 citations · Full text
Medicine, Oncology, Pharmacology +14
Janine T. Erler, Christopher Cawthorne, Kaye J. Williams et al. · Molecular and Cellular Biology · 2004 · 389 citations · Full text
Medicine, Cancer Biology, Oncology +17